Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 USD | -29.34% | -36.41% | -48.65% |
Chart calendar Avenue Therapeutics, Inc.
Upcoming events on Avenue Therapeutics, Inc.
Past events on Avenue Therapeutics, Inc.
2024-04-04 11:00 | Investor Meeting - Key Opinion Leader |
2024-03-18 16:05 | Q4 2023 Earnings Release |
2024-03-13 13:30 | American Society for Experimental Neurotherapeutics Meeting |
2024-01-18 10:00 | Sidoti Micro Cap Investor Conference |
2023-12-02 12:00 | American Epilepsy Society Meeting - Poster Number :444 |
2023-11-30 | American Epilepsy Society Meeting |
2023-11-13 16:05 | Q3 2023 Earnings Release |
2023-09-11 07:00 | H.C. Wainwright Global Investment Conference |
2023-08-10 16:15 | Q2 2023 Earnings Release |
2023-06-22 09:30 | Annual General Meeting |
2023-05-12 08:30 | Q1 2023 Earnings Release |
2023-05-04 16:00 | Aegis Capital Virtual Conference |
2023-03-30 16:01 | Q4 2022 Earnings Release |
2023-01-30 15:00 | Annual General Meeting |
2022-11-10 16:10 | Q3 2022 Earnings Release |
2022-08-14 | Interim 2022 Earnings Release |
2022-02-23 14:30 | Aegis Capital Virtual Summit |
2021-12-16 09:00 | Annual General Meeting |
2020-10-12 08:30 | IV Tramadol CRL Update Call |
2020-08-14 07:30 | Interim 2020 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -26,3 -25,5 -2.92% | -5,21 -5,41 3.59% | -8,04 -4,83 -66.49% | -14,5 -10,5 -37.95% | -13,3 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,9 -25,2 -2.76% | -5,15 -5,12 -0.52% | 0,00 0,00 - | -10,5 -9,58 -9.54% | -13,3 |
Net income Million USD | Released Forecast Spread | -25,9 -25,2 -2.76% | -5,15 -5,12 -0.52% | -3,55 -4,83 26.4% | -10,4 -9,37 -10.69% | -13,3 |
EPS USD | Released Forecast Spread | -1 856 -1 800 -3.12% | -349 -349 0% | -122 -159 23.11% | -73,5 -73,1 -0.51% | -30,8 |
Announcement Date | 30/03/20 | 31/03/21 | 30/03/23 | 18/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | |
EBIT Million USD | Released Forecast Spread | -3,91 -0,70 -458.86% | -6,43 -0,90 -614.33% | -3,92 -1,00 -292.3% | -2,07 -1,50 -37.87% | -2,12 -2,35 9.83% | -3,06 | -3,19 | -3,46 | -3,59 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,62 -2,70 122.85% | -3,06 | -3,19 | -3,46 | -3,59 | |||||
Net income Million USD | Released Forecast Spread | -0,66 | 0,58 -0,70 182.26% | -7,54 -0,90 -738.26% | -4,01 -1,73 -131.75% | 0,53 -2,23 123.59% | 0,64 -2,48 125.76% | -3,06 | -3,19 | -3,46 | -3,59 |
EPS USD | Released Forecast Spread | -33,8 | 92,3 -11,3 920% | -103 -9,75 -953.85% | -39,0 -21,8 -79.31% | 4,50 -19,5 123.08% | 42,0 -7,50 660% | -9,00 | -7,50 | -8,25 | -6,75 |
Announcement Date | 10/11/22 | 30/03/23 | 10/05/23 | 10/08/23 | 13/11/23 | 18/03/24 | - | - | - | - |
Past sector events for Avenue Therapeutics, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ATXI Stock
- Calendar Avenue Therapeutics, Inc.